Form 4: Aeluma Director Byron Reports Equity Acquisition

Aeluma, Inc. Director Michael Byron reported the acquisition of 13,343 restricted stock units and 3,653 fully vested stock options.

Summary

• Director Michael Byron acquired 13,343 shares of Common Stock in the form of Restricted Stock Units (RSUs) on December 3, 2025, at a price of $0.
• These RSUs are scheduled to vest in tranches: approximately 1/12 on December 31, 2025; 1/4 on March 31, June 30, and September 30, 2026; and 1/6 on November 30, 2026.
• Byron also acquired 3,653 stock options on September 1, 2025, with an exercise price of $18.27.
• These stock options were fully vested on the transaction date and have an expiration date of September 1, 2035.
• A Power of Attorney was granted by Michael Byron on January 31, 2026, authorizing several individuals to file SEC reports on his behalf.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting a director's increased equity stake and alignment with shareholder interests, typical of ongoing compensation practices.

Positives

• The acquisition of restricted stock units and stock options by a director indicates alignment of interests with shareholders and confidence in the company's future performance.
• The stock options are fully vested, providing immediate potential for the director to exercise them.

Negatives

• The acquisition price of $0 for the restricted stock units suggests they are part of compensation, which can lead to dilution of existing shareholder value if not tied to performance.
• The exercise price of $18.27 for the stock options sets a benchmark that the stock price needs to exceed for the options to be 'in the money'.

Risks

• The vesting schedule for the restricted stock units extends into late 2026, meaning the full benefit to the director is contingent on continued employment and company performance over that period.
• The value of the stock options is dependent on the future market price of Aeluma, Inc. common stock exceeding the $18.27 exercise price.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance regarding the company's performance or strategic direction, beyond the vesting schedule of the RSUs and the expiration of the options.

Management Comments

• Intentional misstatements or omissions of facts constitute Federal Criminal Violations.

Industry Context

StockSavvy.ai notes that insider equity acquisitions, particularly by directors, are often viewed positively by the market as they signal management's belief in the company's future prospects. This is a routine compensation event for a director.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, restricted stock units, and stock options, aligning with common industry practices for executive and board remuneration in technology and growth-oriented companies.
• The vesting schedule for RSUs, extending over several quarters, is a standard mechanism to encourage long-term retention and performance alignment, comparable to practices at companies like Apple or Microsoft for their executives.
• The grant of fully vested stock options at a specific exercise price is also a common incentive, similar to those seen at companies such as Google (Alphabet) or Amazon, where options are used to motivate performance relative to a market price.

Corporate Governance

Stakeholder Impact

• Shareholders: The acquisition of equity by a director can be seen as a positive signal of confidence in the company's future. The RSUs and options are part of compensation, which can lead to minor dilution over time if new shares are issued.
• Management: The Power of Attorney streamlines compliance for the director and the legal team responsible for SEC filings.

Next Steps

• Vesting of restricted stock units on December 31, 2025, March 31, 2026, June 30, 2026, September 30, 2026, and November 30, 2026.
• Potential exercise of stock options by September 1, 2035.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction related to director compensation. While insider buying can be a positive signal, this specific acquisition of RSUs and options at a $0 acquisition price (for RSUs) and a specific exercise price (for options) is a standard part of an executive compensation package rather than an open market purchase. It does not provide new fundamental information that would warrant a change in investment thesis, thus a 'hold' recommendation is appropriate as it maintains current positions without suggesting new buying or selling based solely on this administrative filing.

Keywords

Aeluma Inc., ALMU, Form 4, Insider Transaction, Director Compensation, Restricted Stock Units, Stock Options, Equity Acquisition, Michael Byron, SEC Filing